Dr. Steven John Terrini, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 17257 Sandalwood Way, Morgan Hill, CA 95037 Phone: 408-612-8607 |
Dr. Matthew Gerst, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 17705 Hale Ave, Suite F-3, Morgan Hill, CA 95037 Phone: 408-776-1990 Fax: 408-776-1901 |
Dr. David Arnold Sandberg, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 90 W Main Ave, Suite 1, Morgan Hill, CA 95037 Phone: 408-722-6163 Fax: 408-779-5351 |
Dr. Brenda Kathleen Mcgowan Sass, PHD Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 60 W Main Ave, Suite 11a, Morgan Hill, CA 95037 Phone: 408-779-2700 Fax: 408-778-9588 |
Dr. Robert Thomas Mulcahy Jr., PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 50 W Main Ave, Suite C, Morgan Hill, CA 95037 Phone: 408-779-4408 |
Maryanne Quinn, LMFT, PSY.D Psychologist Medicare: Not Enrolled in Medicare Practice Location: 16700 Gnarled Oak Ln, Morgan Hill, CA 95037 Phone: 408-569-0744 |
Mr. Jeffrey Eugene Bettencourt, LMFT;LEP Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 18181 Butterfield Blvd Ste 105, Morgan Hill, CA 95037 Phone: 408-203-4401 |
Carol A Johnson-schroetlin, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 605 Tennant Ave Ste I, Morgan Hill, CA 95037 Phone: 408-887-2008 |
News Archive
It's been almost two weeks since the Food and Drug Administration missed its deadline to announce the results of a new safety assessment of the toxic plastics chemical bisphenol A, or BPA, and each day more newborn babies and pregnant women are left unprotected from this hormone-disrupting compound linked to breast cancer and birth defects.
The researchers hope to gain a deeper understanding of how our immune system functions from their detailed study of lymph node processes.
Archer Daniels Midland Company and Rennovia, Inc. announced today that ADM has committed to a $25 million equity investment in the privately held company, which develops catalysts and processes for the cost-advantaged production of chemical products from renewable feedstocks.
A team of researchers at Massachusetts General Hospital has developed a new platform that can rapidly identify effective drug combinations for lung cancer patients whose tumors have stopped responding to targeted therapy. The research, which was supported in part by the National Foundation for Cancer Research, is a critical milestone on the road to personalized medicine.
› Verified 8 days ago